Nov 6, 2025
On November 11, Vicente LLP partner Jason Tarasek and senior associate Yolanda Clarke will join the 2025 Indigenous Cannabis Industry Association Policy Summit in Washington, D.C., to share insights on federal and Tribal cannabis policy developments and the future of Minnesota’s cannabis market. Register now!
Oct 22, 2025
On October 28, Vicente LLP partner Jason Tarasek will speak on a Zuanic & Associates webinar exploring key challenges and opportunities following the launch of Minnesota’s adult-use cannabis market. Register now!
Oct 16, 2025
Vicente LLP will join a panel of legal and banking experts for the upcoming webinar CLE program titled Banking Issues in the Cannabis Industry: Managing Risks Under State and Federal Law; Recent Developments on November 12, 2025 at 1:00 PM ET
Sep 29, 2025
Vicente partner Jason Tarasek will lead a breakout session at the 2025 Real Estate Institute October 24, 2025 in St. Paul, highlighting the top cannabis law updates impacting real estate attorneys and professionals. Register now!
Sep 18, 2025
Vicente LLP is proud to announce that 15 members of our cannabis and psychedelics practices have been recognized in the 2025 Top 200 global industry directories! We’re grateful for the acknowledgement of our team’s dedication and expertise in these industries.
Aug 28, 2025
Vicente partner Jason Tarasek will mediate a panel at the Minnesota Cannabis Real Estate Summit on September 10, 2025. The session will showcase best practices related to safety, efficiency, and compliance in cannabis operations. Register now!
Aug 14, 2025
Vicente partner Jason Tarasek will attend Green Equity: A Cannabis Leadership Summit in Minneapolis on August 18. The event, hosted by the Minority Cannabis Business Association, aims to build equity and opportunity within the cannabis industry.
Jun 5, 2025
Vicente LLP is proud to once again earn Band 1 Nationwide rankings for both Cannabis Law and Psychedelics Law in the Chambers USA 2025 Guide—reaffirming our position as the leading firm in these emerging sectors. Since the introduction of Cannabis Law in 2019 and Psychedelics Law in 2024, we’ve consistently led the field with a proven track record, bold policy leadership, and a steadfast commitment to our clients.
By Charles Alovisetti
Apr 16, 2025
Trump’s return to the White House brings renewed uncertainty for cannabis and hemp policy. This blog breaks down his appointees’ stances, key campaign statements, and what the industry can expect in the months ahead.
By Shawn Hauser, Andrew Livingston
Jan 31, 2025
The much-anticipated hearings on the proposed rulemaking to reschedule cannabis, which were scheduled to begin on January 21, have been postponed for at least three months as a result of an appeal granted by DEA Administrative Law Judge John Mulrooney. In this article, we examine a timeline of progress on rescheduling so far and discuss what may happen next and how the new administration may affect the process.
Oct 30, 2024
Vicente director of economics and research Andrew Livingston will present on the panel “National Cannabis Policy Perspectives” during the Cannabis Law Section of the Nevada State Bar’s Annual Cannabis Conference on November 5.
Oct 24, 2024
Campaign leaders and experts at Vicente LLP and Marijuana Policy Project discuss the details of various cannabis reform initiatives on the 2024 election ballot and potential opportunities in Florida, Nebraska, North Dakota, Oregon, and South Dakota's cannabis markets during this webinar. Plus, panelists provide an update on psychedelic reform in Massachusetts.
By Daniel Molina, Shawn Hauser
Aug 30, 2024
With an upcoming legislative session that will consider medical cannabis expansion, hemp regulation, decriminalization, and other cannabis matters—we have our eyes on Texas! Read the first blog of our Texas series which covers updates on cannabis reform and decriminalization measures in cities like Dallas and Austin, which are set to be on the ballot in November.
By Jason Adelstone
Jul 24, 2024
Despite growing public support, EU nations face significant legal hurdles in establishing commercial marijuana markets due to international drug treaties and EU regulations. This Insights post highlights the various approaches toward cannabis reform taken by countries like Germany, Malta, the Netherlands, Switzerland, and the Czech Republic, and how this could potentially impact future cannabis policies in Europe.
By Jason Adelstone
May 20, 2024
In a recent House Committee meeting with DEA Administrator Anne Milgram, Rep. Andrew S. Clyde voiced his opposition to removing marijuana from Schedule I based on public safety reasons, but then contradicted himself by stating marijuana is “not as dangerous as some of the others we have talked about” (the meeting focused primarily on fentanyl’s harms to communities). This blog post addresses the false narratives and misconceptions that opponents of cannabis reform continue to promote.
By Michelle Bodian
May 17, 2024
This was a big week for hemp (as well as marijuana)! The proposed rules to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) were released and will be officially published in the federal register on May 21, 2024. Some of the language is relevant to hemp and hemp products. Additionally, the U.S. House of Representatives released draft text for the 2023 Farm Bill. Read this insight for key takeaways.
May 7, 2024
On May 8, Vicente’s director of economics and research, Andrew Livingston, is joining Rootwurks for a webinar to break down what it will mean for the cannabis industry now that the DEA is making moves to reclassify cannabis into schedule III—and what work for legalization remains to be done. Register now!
By Shawn Hauser
May 7, 2024
Vicente LLP partner Shawn Hauser argues in a new Marijuana Moment op-ed that the federal decision to reschedule cannabis is “a historic and critically important shift”—with the government “finally (and officially) recognizing the efficacy and safety of cannabis for medical use.”
May 3, 2024
Watch this special briefing featuring Vicente LLP leaders who have been deeply immersed in the federal scheduling issue, along with Mitzi Keating, a CPA and partner at Citrin Cooperman.
By Jason Adelstone
Apr 29, 2024
After listening to the House Oversight and Accountability Committee Hearing with the Commissioner of the FDA on April 11, one conclusion was reinforced—opponents of marijuana reform are misinformed and rely on misstating facts to support their position. Those against moving marijuana into schedule III are making their voices heard, but almost universally, those voices simply do not understand what schedule III would mean.
By Jason Adelstone
Mar 21, 2024
The International Narcotics Control Board (INCB) may be taking a more measured approach to cannabis. In their 2023 report, INCB used the word "may" when discussing potential inconsistencies between US state legalization and international treaties. This subtle shift in language suggests a more open-minded approach. This blog post explores the significance of this change in the report’s language and what it might mean for the future of global cannabis legalization.
By Jason Tarasek
Feb 2, 2024
Minnesota dispensaries could be a reality by summer! The OCM unveiled an ambitious plan to speed up the launch, proposing temporary regulations and licensing reforms. Focusing on social equity, product availability, and education, they are streamlining the process by removing initial premise requirements, local government involvement, and even suggesting a new social equity classification. Read this Insights post for the latest update on Minnesota’s cannabis business regulations.
By Jason Adelstone
Jan 30, 2024
On August 29, 2023, the Department of Health and Human Services (“HHS”) sent the Drug Enforcement Administration (“DEA”) its recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). Since then, the marijuana industry has waited in suspense for the DEA to make the final call as to what schedule marijuana will be placed. Read this Insights post that outlines the complex process of marijuana rescheduling in the US and outlines the key steps involved, from rule publication to review and final rule, emphasizing the critical role of stakeholder engagement in securing a Schedule III classification.
Oct 25, 2023
Andrew Livingston will present on cannabis supply and demand and Sally Kent Peebles will present on leveraging opportunities in new markets at MJBizCon this year. Read on for more information about their panels!